Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,194 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Concordance of Inivata Liquid Biopsy With Standard Tissue Biopsy

NCT03116633

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Mercy Hospital Cancer Center/Clinical Research Fort Smith, Arkansas, United States
  • Mercy Cancer Center Joplin, Missouri, United States
  • Mercy Clinic Springfield, Missouri, United States
  • Mercy Clinic Oncology & Hematology Oklahoma City, Oklahoma, United States
View Trial Details
Completed

Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing

NCT02906852

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Facey Medical Foundation Mission Hills, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Eastern CT Hematology Oncology Norwich, Connecticut, United States
  • Christiana Care Health Services Inc Newark, Delaware, United States
View all 35 locations
View Trial Details
Completed

Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung Cancer

NCT01866410

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
View Trial Details
Completed

Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202)

NCT03059797

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • The 307th Hospital of Chinese People's Liberation Army Beijing, Beijing Municipality, China
  • Guangdong General Hospital Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
View Trial Details
Completed

E-MOSAIC Electronic Tool to Monitor Symptoms

NCT00477919

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +115 more
Locations
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
  • Spital Buelach Bülach, Switzerland
View Trial Details
Completed

Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).

NCT01116219

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations
  • Kantonsspital Aarau Aarau, Switzerland
  • Kantonsspital Baden Baden, Switzerland
  • Saint Claraspital AG Basel, Switzerland
  • Clinical Cancer Research Center at University Hospital Basel Basel, Switzerland
View all 22 locations
View Trial Details

Related conditions